Hardy N - Search Results

1

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Porter DL, Alyea EP, Antin JH, DeLima M, Estey E, Falkenburg JH, Hardy N, Kroeger N, Leis J, Levine J, Maloney DG, Peggs K, Rowe JM, Wayne AS, Giralt S, Bishop MR, van Besien K. Porter DL, et al. Among authors: hardy n. Biol Blood Marrow Transplant. 2010 Nov;16(11):1467-503. doi: 10.1016/j.bbmt.2010.08.001. Epub 2010 Aug 10. Biol Blood Marrow Transplant. 2010. PMID: 20699125 Free PMC article.

2

Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation.

Salit RB, Fowler DH, Dean RM, Pavletic SZ, Hakim FT, Steinberg SM, Hardy NT, Sportes C, Gress RE, Bishop MR. Salit RB, et al. Biol Blood Marrow Transplant. 2013 Oct;19(10):1509-13. doi: 10.1016/j.bbmt.2013.08.001. Epub 2013 Aug 13. Biol Blood Marrow Transplant. 2013. PMID: 23948062 Free PMC article.

3

Surgeon assessment of significant rectal polyps using white light endoscopy alone and in comparison to fluorescence-augmented AI lesion classification.

Hardy NP, Moynihan A, Dalli J, Epperlein JP, McEntee PD, Boland PA, Neary PM, Cahill RA. Hardy NP, et al. Langenbecks Arch Surg. 2024 Jun 1;409(1):170. doi: 10.1007/s00423-024-03364-2. Langenbecks Arch Surg. 2024. PMID: 38822883 Free PMC article.

4

Clinical and computational development of a patient-calibrated ICGFA bowel transection recommender.

Dalli J, Epperlein JP, Hardy NP, Khan MF, Mac Aonghusa P, Cahill RA. Dalli J, et al. Among authors: hardy np. Surg Endosc. 2024 Jun;38(6):3212-3222. doi: 10.1007/s00464-024-10827-6. Epub 2024 Apr 18. Surg Endosc. 2024. PMID: 38637339 Free PMC article.

5

Technical and functional design considerations for a real-world interpretable AI solution for NIR perfusion analysis (including cancer).

Moynihan A, Boland P, Cucek J, Erzen S, Hardy N, McEntee P, Rojc J, Cahill R. Moynihan A, et al. Among authors: hardy n. Eur J Surg Oncol. 2024 Mar 18:108273. doi: 10.1016/j.ejso.2024.108273. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 38538505 Free article.

6

A feasibility study assessing quantitative indocyanine green angiographic predictors of reconstructive complications following nipple-sparing mastectomy.

Dalli J, Nguyen CL, Jindal A, Epperlein JP, Hardy NP, Pulitano C, Warrier S, Cahill RA. Dalli J, et al. Among authors: hardy np. JPRAS Open. 2024 Jan 26;40:32-47. doi: 10.1016/j.jpra.2024.01.012. eCollection 2024 Jun. JPRAS Open. 2024. PMID: 38425697 Free PMC article.

7

Geotemporal Fluorophore Biodistribution Mapping of Colorectal Cancer: Micro and Macroscopic Insights.

Hardy NP, Mulligan N, Dalli J, Epperlein JP, Neary PM, Robertson W, Liddy R, Thorpe SD, Aird JJ, Cahill RA. Hardy NP, et al. Curr Oncol. 2024 Feb 2;31(2):849-861. doi: 10.3390/curroncol31020063. Curr Oncol. 2024. PMID: 38392057 Free PMC article.

8

Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.

Kline K, Luetkens T, Koka R, Kallen ME, Chen W, Ahmad H, Omili D, Iraguha T, Gebru E, Fan X, Miller A, Dishanthan N, Baker JM, Dietze KA, Hankey KG, Yared JA, Hardy NM, Rapoport AP, Dahiya S, Atanackovic D. Kline K, et al. Among authors: hardy nm. Cancer Immunol Immunother. 2024 Feb 13;73(3):45. doi: 10.1007/s00262-023-03619-9. Cancer Immunol Immunother. 2024. PMID: 38349430 Free PMC article.

9

A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products.

Atanackovic D, Iraguha T, Omili D, Avila SV, Fan X, Kocoglu M, Gebru E, Baker JM, Dishanthan N, Dietze KA, Oluwafemi A, Hardy NM, Yared JA, Hankey K, Dahiya S, Rapoport AP, Luetkens T. Atanackovic D, et al. Among authors: hardy nm. Cytotherapy. 2024 Apr;26(4):318-324. doi: 10.1016/j.jcyt.2024.01.006. Epub 2024 Feb 10. Cytotherapy. 2024. PMID: 38340107

10

Analysis of general payments from industry to dermatology nonphysician clinicians in the United States, 2021-2022.

Hardy NJ, Gronbeck C, Feng H. Hardy NJ, et al. J Am Acad Dermatol. 2024 May;90(5):1025-1028. doi: 10.1016/j.jaad.2024.01.003. Epub 2024 Feb 1. J Am Acad Dermatol. 2024. PMID: 38300171 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

336 results

Search Page